Aisling Capital Management LP cut its stake in shares of Aclaris Therapeutics, Inc. ( NASDAQ:ACRS – Get Rating ) by 31.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 434,455 shares of the biotechnology company's stock after selling 200,000 shares during the quarter. Aclaris Therapeutics makes up 4.5% of Aisling Capital Management LP's portfolio, making the stock its 5th largest holding. Aisling Capital Management LP owned about 0.65% of Aclaris Therapeutics worth $6,843,000 as of its most recent filing with the SEC.

https://www.dailypolitical.com/2023/05/12/aisling-capital-management-lp-has-6-84-million-stock-position-in-aclaris-therapeutics-inc-nasdaqacrs.html

#dailypolitical